CEACAM6 is increased in pancreatic adenocarcinoma, breast cancer, non small cell lung cancer, gastric cancer, colon cancer and other cancers and promotes tumor progression, invasion, and metastasis [4]. This evidence concerns the gene CEACAM6 and pancreatic adenocarcinoma.